Corrigendum to "Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin" [Bioorg. Med. Chem. Lett. 32 (2021) 127683].

Corrigendum to "Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin" [Bioorg. Med. Chem. Lett. 32 (2021) 127683].
Bioorg Med Chem Lett. 2021 Feb 13;37:127836
Authors: Kahlon G, Lira R, Masvlov N, Pompa E, Brar N, Eagon S, Anderson MO, Andaya A, Chance JP, Fejzic H, Keniston A, Huynh N, Celis N, Vidal B, Trieu N, Rodriguez P, Mallari JP
PMID: 33588181 [PubMed - as supplied by publisher]

Source: Bioorganic and Medicinal Chemistry Letters - February 13, 2021 Category: Chemistry Authors: Kahlon G, Lira R, Masvlov N, Pompa E, Brar N, Eagon S, Anderson MO, Andaya A, Chance JP, Fejzic H, Keniston A, Huynh N, Celis N, Vidal B, Trieu N, Rodriguez P, Mallari JP Tags: Bioorg Med Chem Lett Source Type: research